CTRI/2018/02/011662已完成4 期
To Compare The Efficacy And Safety Of Escitalopram & Vilazodone In Major Depressive Disorder
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •newly diagnosed patients who meet the DSM 5 criteria for depression
排除标准
- •(i) severe comorbid conditions like diabetes, hypertension & ischemic heart disease (ii) patients taking antidepressans in the last 6 weeks (iii) pregnant or lactating females (iv) intake of other drugs for psychosis or anxiety (v) history of substance abuse (vi) any chronic ailment or drug intake leading to depression (vii)) patients with neurological disorders such as stroke, dementia or seizures.
研究者
相似试验
招募中
3 期
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
招募中
不适用
escitalopram in depressive patients with acute coronary artery syndromeMental and behavioral disordersKCT0000053Chonnam National University Hospital300
已完成
3 期
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
已完成
不适用
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorderJPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200
已完成
2 期
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172